Filter Results
:
(3)
Show Results For
-
All HBS Web
(3)
- Research (1)
- Faculty Publications (1)
Show Results For
-
All HBS Web
(3)
- Research (1)
- Faculty Publications (1)
Page 1 of
3
Results
- May 2014 (Revised January 2015)
- Case
Vaxess Technologies, Inc.
By: John A. Quelch and Margaret L. Rodriguez
In February 2014, Michael Schrader, chief executive of Vaxess Technologies, Inc., was assessing the startup health care company's 2014 marketing plan. On December 31st, 2013, Vaxess had obtained an exclusive license to a series of patents for a silk protein technology...
View Details
Keywords:
Vaccine;
Cold Chain;
Antigen;
Temperature Controlled;
Developing Markets;
Immunization;
Health Care and Treatment;
Health Pandemics;
Global Strategy;
Supply Chain;
Health;
Health Industry;
Medical Devices and Supplies Industry
Quelch, John A., and Margaret L. Rodriguez. "Vaxess Technologies, Inc." Harvard Business School Case 514-107, May 2014. (Revised January 2015.)
- Web
Curriculum - MBA
research. Topics will include in vitro microbial discovery platforms; engineering strategies such as chimeric, humanized, and human Abs; human Fc engineering; and nanobodies, antibody drug conjugates, and immunotoxins and chimeric antigen...
View Details
- Web
FAQs - Alumni
restrictions for their return destination and any transition locations. Please note that Harvard Business School and Harvard University Health Services are not able to provide monitored antigen or ad hoc PCR tests. Any individual in our...
View Details